Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly

NCT00772889 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00772889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00772889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
October 9, 2008
Completion date
December 15, 2009
Enrollment
971 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

influenza